Amgen wins injunction in Sanofi Repatha suit

06-01-2017

Amgen wins injunction in Sanofi Repatha suit

Lemau Studio / Shutterstock.com

Sanofi and Regeneron Pharmaceuticals must stop selling cholesterol-lowering medicine Praluent (alirocumab) after Amgen obtained an injunction against the companies.


Amgen, Sanofi, Regeneron Pharmaceuticals, patent, patent infringement, evolocumab, Repatha, Praluent, injunction

LSIPR